Shin Nippon Biomedical Laboratories, Ltd. (OTCMKTS:SBLOF) Short Interest Update

Shin Nippon Biomedical Laboratories, Ltd. (OTCMKTS:SBLOF) saw a significant drop in short interest in August. As of August 31st, there was short interest totaling 25,129 shares, a drop of 44.9% from the August 15th total of 45,628 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is presently ∞ days.

Shin Nippon Biomedical Laboratories Price Performance

Shin Nippon Biomedical Laboratories stock remained flat at $7.00 during trading hours on Thursday. The stock’s fifty day moving average is $7.00 and its 200-day moving average is $8.19. Shin Nippon Biomedical Laboratories has a 52-week low of $7.00 and a 52-week high of $9.16.

Shin Nippon Biomedical Laboratories Company Profile

Shin Nippon Biomedical Laboratories, Ltd. (OTCMKTS: SBLOF) is a Japan‐based contract research organization specializing in nonclinical safety assessment for the pharmaceutical, biotechnology and agrochemical industries. Established in 1978 and headquartered in Kagoshima, the company provides a range of preclinical testing services designed to support drug development from early discovery through regulatory submission. SBLOF is known for its adherence to Good Laboratory Practice (GLP) standards and its focus on high‐quality data generation and compliance.

The company’s core services include toxicology studies, pharmacokinetics and bioanalysis, safety pharmacology, pathology and genetic toxicology.